LOS ANGELES, CA--(Marketwired - October 24, 2016) - With legal marijuana expected to make further inroads this November, MedMen, the nation's leading cannabis firm, and IMN, a global organizer of institutional finance and investment conferences, announced they will host the country's first ever cannabis expo for institutional and accredited investors.
The inaugural Institutional Capital & Cannabis Conference (IC3) will take place March 28 and 29, 2017 in San Jose, California. The program will provide an in-depth look into the emerging cannabis industry and attendees will learn how to evaluate investment returns in legal cannabis relative to other more traditional investments.
Although past investor forums have included individual panels on cannabis, and marijuana ventures have hosted investor events, this is the first time a major finance and investment conference organizer has launched an expo dedicated exclusively to opportunities in the emerging cannabis space.
Legal cannabis is the fastest growing industry in America. A majority of American adults already live in states where marijuana is legal in some form or another. This November, a total of nine states will consider marijuana legalization measures, including full legalization in California, Nevada, Arizona, Massachusetts and Maine. Annual sales have grown by double digit rates in recent years and they are projected to hit $80 billion in the next decade.
"No serious investor can ignore this industry today," said Julius Hill, CEO of IMN, which organizes investor forums across the world in the areas of structured finance, real estate, investment management and distressed assets. "Emerging industries do not happen every day. Returns like this do not happen every day. But you still need to understand the playing field, and you need to have a strategy and a roadmap. This event has been created specifically with the needs of the institutional and accredited investor in mind."
MedMen, based in Los Angeles, operates a turnkey management services company and a capital arm. The company has operations and exposure throughout North America, and a track record of helping more than 100 cannabis businesses thrive in this complex industry. This summer, the capital arm launched the industry's first $100 million private equity fund.
"We are at a tipping point in this industry," said MedMen co-founder and CEO Adam Bierman. "Imagine if you had an opportunity to stake your share of the adult beverage industry just before the end of Prohibition. This is our generation's Prohibition, and we believe wholeheartedly that it is coming to an end."
MedMen is a leading cannabis firm based in Los Angeles with operations across North America. The Firm operates in two areas; MedMen Management offers turnkey services to cannabis license holders, and MedMen Capital makes strategic investments in key markets across the U.S. and Canada. Visit http://www.medmen.com.
IMN, founded in 1994, is a global organizer of institutional finance & investment conferences. In 2004 the business was acquired by Euromoney Institutional Investor PLC, a UK company listed on the London Stock Exchange. Visit https://www.imn.org/.